| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 82981 |
PLA-SS-PEG-NHS(聚乳酸-双硫键-聚乙二醇-活性酯) |
165 |
WYQ |
2024-12-23 |
| 82982 |
cas:1190-14-3,4-bromobutylphosphonic acid,(4-溴丁基)膦酸 |
252 |
kx |
2024-12-23 |
| 82983 |
HSPC:Chol:DSPE-mPEG2000 Liposomes,氢化大豆磷脂酰胆碱-胆固醇-聚乙二醇化二硬脂酰磷脂酰乙醇胺脂质体 |
803 |
axc |
2024-12-23 |
| 82984 |
ALD-tetra-EG-Osu,ADC定制 |
177 |
wyh |
2024-12-23 |
| 82985 |
Soy PS:Chol Liposomes,磷脂酰丝氨酸:胆固醇组成的脂质体 |
479 |
axc |
2024-12-23 |
| 82986 |
Glutamic acid–valine–citrulline linkers,抗体药物偶联物(ADC) |
323 |
kx |
2024-12-23 |
| 82987 |
DOTA-RGD,大环螯合物DOTA |
227 |
zyl |
2024-12-23 |
| 82988 |
Gd-DOTA-多肽的介绍 |
259 |
zyl |
2024-12-23 |
| 82989 |
Brain PS:Chol Liposomes,脑磷脂酰丝氨酸:胆固醇脂质体 |
246 |
axc |
2024-12-23 |
| 82990 |
Fab-PEG24-PEGF,Fab-二十四聚乙二醇-PEGF |
180 |
h |
2024-12-23 |
| 82991 |
cas:1616668-55-3,Tetrazine-NHS ester,四嗪-NHS酯 |
160 |
kx |
2024-12-23 |
| 82992 |
NOTA-PEG6-TATE NOTA-六聚乙二醇-奥曲肽 |
158 |
h |
2024-12-23 |
| 82993 |
PCL-SS-PEG-NH2(聚己内酯-双硫键-聚乙二醇-胺) |
158 |
WYQ |
2024-12-23 |
| 82994 |
HBFP-PEG14 交联的超支化含氟聚合物和聚乙二醇两亲网络 |
180 |
h |
2024-12-23 |
| 82995 |
cas:35638-19-8,1,3-bis(carboxyethoxy)-2,2-bis(carboxyethoxy)propane, ADC试剂 |
128 |
kx |
2024-12-23 |
| 82996 |
MLR2-PEI-PEG12,十二聚乙二醇-PEI-MLR2 |
213 |
h |
2024-12-23 |
| 82997 |
Ag-S-(CH2)11-N-(CH3)3+Cl- 银-硫-十一烷烃-N-(CH3)3+氯- |
165 |
zyl |
2024-12-23 |
| 82998 |
MV-PEG12 一端含有甲基紫精部分的12聚乙二醇 |
203 |
h |
2024-12-23 |
| 82999 |
DSPE-SS-PEG-CY5(磷脂-双硫键-聚乙二醇-菁染料Cy5) |
161 |
WYQ |
2024-12-23 |
| 83000 |
perfluorophenyl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oate, ADC试剂 |
151 |
kx |
2024-12-23 |
| 83001 |
Au_12_C10COOH 金团簇12-C10-羧酸 |
223 |
zyl |
2024-12-23 |
| 83002 |
cas:1193111-73-7,2,5-dioxopyrrolidin-1-yl 2-(dimethylamino)-4-(pyridin-2-yldisulfanyl)butanoate, ADC试剂 |
145 |
kx |
2024-12-23 |
| 83003 |
Au_55_C11CH3 金团簇55-C11-甲烷3 |
171 |
zyl |
2024-12-23 |
| 83004 |
NH2-SS-PEG-cRGD(氨基-双硫键-聚乙二醇-环肽) |
228 |
WYQ |
2024-12-23 |
| 83005 |
cas:866363-70-4,2,5-dioxopyrrolidin-1-yl 6-azidohexanoate,6-叠氮己酸琥珀酰亚胺酯 |
137 |
kx |
2024-12-23 |
| 83006 |
Au-S-(CH2)10-COO-NHS 金-硫-十烷烃-COO-N-羟基琥珀酰亚胺 |
203 |
zyl |
2024-12-23 |
| 83007 |
1-(4-methyl-4-(pyridin-2-yldisulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid, ADC试剂 |
134 |
kx |
2024-12-23 |
| 83008 |
(S-(CH2)11-beta-LAC(SO4Na)7)2 硫-十一烷烃-β-麦芽糖 |
153 |
zyl |
2024-12-23 |
| 83009 |
cas:45233-75-8 , Boc-Val-Gly-OH,BOC-缬氨酰-甘氨酸 |
162 |
kx |
2024-12-23 |
| 83010 |
HS-(CH2)10-O-Disperse Red 1 十烷烃硫醇化荧光配体 |
241 |
zyl |
2024-12-23 |
| 83011 |
DSPE-SS-PEG-FITC(二硬脂酰基磷脂酰乙醇胺-双硫键-聚乙二醇-荧光素) |
245 |
WYQ |
2024-12-23 |
| 83012 |
TCO-PEG4-Val-Cit-PAB-PNP,反式环辛烯-四聚乙二醇-VAL-CIT-PAB-PNP 酯 |
299 |
kx |
2024-12-23 |
| 83013 |
(HO)2-PO-S-(CH2)6-EG4-OH 硫-(4-羟基六烷-1-基)硫代磷酸酯 |
255 |
zyl |
2024-12-23 |
| 83014 |
PLA-SS-PEG-FA 聚乳酸-双硫键-聚乙二醇-叶酸 |
204 |
WYQ |
2024-12-23 |
| 83015 |
cas:2727965-49-1 , Mal-PEG3-Val-Cit-PAB-OH,马来酰亚胺-三聚乙二醇-VAL-CIT-羟基 |
199 |
kx |
2024-12-23 |
| 83016 |
PLA-SS-PEG-cRGD 聚乳酸-双硫键-聚乙二醇-环肽 |
158 |
WYQ |
2024-12-23 |
| 83017 |
PLA-SS-SH, 聚乳酸-双硫键-巯基 |
176 |
WYQ |
2024-12-23 |
| 83018 |
(HO)2-PO-S-(CH2)11-EGn-OH 硫- {2- [2-(2-羟基乙氧基)乙氧基]乙氧基}-烷-1-基硫代磷酸 |
218 |
zyl |
2024-12-23 |
| 83019 |
cas:937025-17-7,2,5-Dioxopyrrolidin-1-yl 2-oxo-6,9,12,15-tetraoxa-3-thiaoctadecan-18-oate |
174 |
wyh |
2024-12-23 |
| 83020 |
Fmoc-PEG4-Glu-Gly-Cit-PAB-OH, ADC试剂 |
158 |
kx |
2024-12-23 |
| 83021 |
Si(OMe)3-(CH2)11-O-CH2-C6F5 甲基硅-直链烷烃-C6F5含氟试剂 |
270 |
zyl |
2024-12-23 |
| 83022 |
DSPE-SS-PEG-CY5 二硬脂酰基磷脂酰乙醇胺-双硫键-聚乙二醇-CY5 |
155 |
WYQ |
2024-12-23 |
| 83023 |
亚氨基二乙酸二异丁酯,Di-tert-butyl iminodiacetate |
152 |
wyh |
2024-12-23 |
| 83024 |
DSPE-SS-PEG2000-N3 二硬脂酰基磷脂酰乙醇胺-双硫键-聚乙二醇-叠氮 |
197 |
WYQ |
2024-12-23 |
| 83025 |
N3-hex-vc-PAB-C6-Amanitin,抗体药物偶联物(ADC) |
174 |
kx |
2024-12-23 |